Tweet When the patent of reference natalizumab (Tysabri) infusion ran out the makers brought out subcutaneous natalizumab (Tysabri) and encouraged the neuros to switch…It also allowed generic makers to make replicas of natalizumab, called a biosimilar because it isn’t identical. Along came the first biosimilar natalizumab (Tyruko) and NICE in their stupidity said switch every…
I trusted my gut, even after hearing I was ‘too young’ to have MS
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
I regained the confidence to travel after my MS diagnosis
In recognition of Multiple Sclerosis Awareness Month in March, the MS Community Spotlight campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSSpotlight, or read the full series….
The Crap Gap with Natalizumab..No clues
Tweet The wearing off effect also known to some as the “CRAP gap” is something that occurs when you get to the end of your treatment cycle. But what is it? AI says “The “wearing-off” effect (WOE) of monoclonal antibodies (MAbs) is a commonly reported phenomenon where therapeutic benefits subside before the next dose is…
Common anti-aging drugs may damage brain’s protective coating
A combination of drugs widely used in anti-aging studies seems to compromise the function of the brain’s myelin-making cells and cause profound myelin loss, according to the findings of a new study in mice and lab-grown cells. The dual treatment, which combines dasatinib and quercetin, also known as D+Q, caused oligodendrocytes — the cells that…
Autoabogacía en acción: Aprendiendo de quienes viven con EM
Al trabajar en la Asociación de Esclerosis Múltiple de América (MSAA, por sus siglas en inglés), a menudo me preguntan si tengo un diagnóstico de esclerosis múltiple (EM). Aun cuando la EM no forma parte de mi historia personal, convivir … Continue reading → Source: blog.mymsaa.org
Advocacy in Action: Learning from People with MS
Working at the Multiple Sclerosis Association of America (MSAA), I am often asked if I have a diagnosis of multiple sclerosis (MS). While MS is not part of my personal journey, speaking with people living with MS has given me … Continue reading → Source: blog.mymsaa.org
My MS diagnosis opened a window to a whole new world
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
De-escalating anti-CD20 works…Does the Result Surprise Me…No!
Tweet The escalating approach to MS was based on failure. Failure drug 1 go to drug 2, fail go to drug 3 and hope that its not too late to limit progression occurring. This is a problem of the softly softly approach but the we’ll wait until I feel I have to do something type…
EBV antibodies in CNS years before MS
Tweet I guesss you all know this, but here is an example of an EBV infection 16 years before MS developed. So what happens in the interviening time and why are things unnoticed. One element to this is neurological researve. So just like the pancreas you can loose stuff before you notice it as such…